Clinical Trial

Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.

Name: Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece. — clinical trial record (NCT07352878)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FEROUSA

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This observational clinical study aims to evaluate the HRQoL of thalassemia patients with iron overload in Greece, who are under treatment with deferasirox based on standard clinical practice.

Trial Details

NCT Number	NCT07352878
Lead Sponsor	Elpen Pharmaceutical Co. Inc. Collaborators: Aghia Sophia Children's Hospital of Athens
Conditions	Thalassemia, Iron Overload
Enrollment	150 participants
Start Date	2026-04-15
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-20